Peyto Exploration & Development Corp. (0VCO)
London Exchange · UK · prices in CAD · close of 21 Oct 2026
Key indicators
| Last close | CAD 25.37 |
|---|---|
| 52-week range | 19.89 – 29.20 |
| Return, 1 month / 3 months | +7.3% / +5.7% |
| Return, 1 year / 3 years | +35.5% / +86.2% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 27.3% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 0.00M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Peyto Exploration & Development Corp. is a Canadian energy company that explores for, develops and produces natural gas and natural gas liquids. Its operations are concentrated in the Deep Basin area of Alberta, where it drills and operates wells and processes the gas it produces. The company is based in Calgary, Alberta, and its customers are the buyers and midstream handlers of the gas and liquids it brings to market.
The shares are listed on the London Exchange in UK under the code 0VCO, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Peyto Exploration & Development Corp. (0VCO) trades on the London Exchange in UK. It last closed at CAD 25.37 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,875 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.5% and over the last three months it rose 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 1.1% | ||
| From 52-week high | -12.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.7% | ||
| 6-month return | 4.0% | ||
| 12-month return, skipping the last month | 26.2% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +7.3% |
| 3 months | +5.7% |
| 6 months | +4.0% |
| 1 year | +35.5% |
| 3 years | +86.2% |
| 5 years | +187.2% |
Signals
| 50-day / 200-day average | 24.52 / 25.09 |
|---|---|
| Golden / death cross (60 days) | Death, 39 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Sep 2021 | CAD 0.0100 |
| 29 Jun 2021 | CAD 0.0100 |
| 30 Mar 2021 | CAD 0.0100 |
| 30 Dec 2020 | CAD 0.0100 |
| 29 Sep 2020 | CAD 0.0100 |
| 29 Jun 2020 | CAD 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.